Biofrontera AG

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

2.10%

Market Cap

14.16 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.65 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE2.48 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 09:55:44 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW2.52.23
PREV. DAY'S PRICE2.33 (07/21)
CHANGE DAY BEFORE
+0.15
6.44 %
52 WEEK HIGH / LOW2.88 (10/06)2.18 (02/03)
More Price Information

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
-0.07-0.72-0.65--
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
1.280.690.99--
PRICE - SALES RATIO
0.790.601.12--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A4BGGM
ISIN
DE000A4BGGM7
SYMBOL
B8FK
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Biofrontera
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
6.08 Mil.
MARKET CAPITALISATION
14.16 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
1.30 %
-0.85 %
-12.41 %
-7.17 %
-2.10 %
-86.66 %
-95.82 %
-1.27 %
HIGH2.362.382.622.852.8817.8557.382.85
LOW2.232.232.192.182.182.002.002.18

Dividende

pro Aktie
Biofrontera does not deliver dividend information

Company profile

Biofrontera AG engages in the research, development, and marketing of dermatological products. Its products include Ameluz, BF-RhodolesXepi and Belixos. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.